WHO ICTRP trial
Modulation de la vasoréactivité dans le choc septique: impact de la protéine C…
EUCTR2007-002319-16-FR · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2007-002319-16-FR |
|---|---|
| Public title | Modulation de la vasoréactivité dans le choc septique : impact de la protéine C recombinante - PCa |
| Scientific title | Modulation de la vasoréactivité dans le choc septique : impact de la protéine C recombinante - PCa |
| Primary sponsor | Centre Hospitalier Universitaire de Nancy |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Countries | France |
| Conditions | sepsis : sont inclus les patients répondant aux critères conventionnels du choc septique qui intègrent ceux d’infection et d’infection sévère MedDRA version: 9.1 Level: LLT Classification code 10040047 Term: Sepsis |
| Interventions | Trade Name: xigris Product Name: Proteine C recombinante (xigris) Pharmaceutical Form: Powder for solution for infusion |
| Registration date | Jul 23, 2007 |
| Secondary IDs | Pr LEVY - PCa - CPRC 2006 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: